Non-Invasive Monitoring Systems (NIMU) 10-K 25 Oct 24 2024 FY Annual report Financial data

Cover

Cover - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Oct. 25, 2024	Jan. 31, 2024
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Jul. 31, 2024
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--07-31
Entity File Number	000-13176
Entity Registrant Name	NON INVASIVE MONITORING SYSTEMS INC /FL/
Entity Central Index Key	0000720762
Entity Tax Identification Number	59-2007840
Entity Incorporation, State or Country Code	FL
Entity Address, Address Line One	4400 Biscayne Blvd.
Entity Address, Address Line Two	Suite 180
Entity Address, City or Town	Miami
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33137
City Area Code	(305)
Local Phone Number	575-4200
Title of 12(b) Security	Common Stock $0.01 par value per share
Trading Symbol	NIMU
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	true
Entity Public Float				$ 2.2
Entity Common Stock, Shares Outstanding			154,810,655
Documents Incorporated by Reference	None
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Listing, Par Value Per Share	$ 0.01
Auditor Firm ID	572	274
Auditor Opinion	We have audited the accompanying consolidated balance sheet of Non-Invasive Monitoring Systems, Inc. (the “Company”) as of July 31, 2024, the related consolidated statements of operations and comprehensive loss, shareholders’ deficit, and cash flows for the year then ended and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of July 31, 2024, and the results of its consolidated operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.	We have audited the accompanying consolidated balance sheet of Non-Invasive Monitoring Systems, Inc. and Subsidiaries (the “Company”) as of July 31, 2023, and the related consolidated statements of operations, changes in shareholders’ deficit, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company as of July 31, 2023, and the consolidated results of their operations and their cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.
Auditor Name	Weinberg & Company, P.A.	EisnerAmper LLP
Auditor Location	Los Angeles, California	Coral Gables, FL

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Current assets
Cash	$ 25	$ 7
Prepaid expenses	9	16
Total current assets	34	23
Total assets	34	23
Current liabilities
Accounts payable and accrued expenses	110	240
Current liabilities - discontinued operations	51	51
Total current liabilities	161	291
Total liabilities	759	635
Commitments and Contingencies
Shareholders’ deficit
Series B Preferred Stock, par value $1.00 per share; 100 shares authorized, issued and outstanding; liquidation preference $10
Common Stock, par value $0.01 per share; 400,000,000 shares authorized; 154,810,655 shares issued and outstanding as of July 31, 2024 and 2023, respectively	1,548	1,548
Additional paid in capital	26,574	26,574
Accumulated deficit	(28,847)	(28,734)
Total shareholders’ deficit	(725)	(612)
Total liabilities and shareholders’ deficit	34	23
Related Party [Member]
Current liabilities
Notes payable – related parties	500	300
Accrued interest – related parties	$ 98	$ 44

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Preferred stock, shares authorized	1,000,000
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	154,810,655	154,810,655
Common stock, shares outstanding	154,810,655	154,810,655
Series B Preferred Stock [Member]
Preferred stock, par value	$ 1	$ 1
Preferred stock, shares authorized	100	100
Preferred stock, shares issued	100	100
Preferred stock, shares outstanding	100	100
Preferred stock, liquidation preference	$ 10	$ 10

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Operating costs and expenses
General and administrative	$ 177,000	$ 169,000
Extinguishment of accounts payable	(118,000)
Total operating costs and expenses	59,000	169,000
Operating loss	(59,000)	(169,000)
Interest expense, related parties	(54,000)	(30,000)
Net loss	$ (113,000)	$ (199,000)
Weighted average number of common shares outstanding - basic	154,811	154,811
Weighted average number of common shares outstanding - diluted	154,811	154,811
Basic loss per common share	$ 0	$ 0
Diluted loss per common share	$ 0	$ 0

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Deficit - USD ($)	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Jul. 31, 2022		$ 1,548,000	$ 26,574,000	$ (28,535,000)	$ (413,000)
Balance, shares at Jul. 31, 2022	100	154,810,655
Net loss				(199,000)	(199,000)
Balance at Jul. 31, 2023		$ 1,548,000	26,574,000	(28,734,000)	(612,000)
Balance, shares at Jul. 31, 2023	100	154,810,655
Net loss				(113,000)	(113,000)
Balance at Jul. 31, 2024		$ 1,548,000	$ 26,574,000	$ (28,847,000)	$ (725,000)
Balance, shares at Jul. 31, 2024	100	154,810,655

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Operating activities
Net loss	$ (113,000)	$ (199,000)
Adjustments to reconcile net loss to net cash used in operating activities
Extinguishment of accounts payable	(118,000)
Changes in operating assets and liabilities
Prepaid expenses	7,000	(10,000)
Accounts payable and accrued expenses	(12,000)	21,000
Accrued interest – related parties	54,000	30,000
Net cash used in operating activities	(182,000)	(158,000)
Financing activities
Proceeds from notes payable – related parties	200,000	150,000
Net cash provided by financing activities	200,000	150,000
Net increase (decrease) in cash	18,000	(8,000)
Cash, beginning of year	7,000	15,000
Cash, end of year	$ 25,000	$ 7,000

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (113,000)	$ (199,000)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jul. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false

ORGANIZATION AND BUSINESS

ORGANIZATION AND BUSINESS	12 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS	1. ORGANIZATION AND BUSINESS Organization. ® Business. Going Concern. 113,000 199,000 29.0 25,000 127,000 The Company is seeking potential mergers, acquisitions and strategic collaborations. There is no assurance that the Company will be successful in this regard, and, if not successful, that it will be able to continue its business activities. The accompanying consolidated financial statements do not include any adjustments that might be necessary from the outcome of this uncertainty. Discontinued Operations. Accordingly, the Company determined that the assets and liabilities met the discontinued operations criteria in Accounting Standards Codification 205-20-45 and were classified as discontinued operations at May 3, 2019. See Discontinued Operations Note 3.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Consolidation Discontinued Operations Use of Estimates Cash and Cash Equivalents 25,000 7,000 Income Taxes The Company files its tax returns as prescribed by the laws of the jurisdictions in which it operates. Tax years ranging from 2020 to 2023 remain open to examination by various taxing jurisdictions as the statute of limitations has not expired. The net operating losses are generally subject to examination up to three years after the utilization of such losses. It is the Company’s policy to include income tax interest and penalty expense in its tax provision. Fair Value of Financial Instruments Loss Contingencies Related Parties Recent Accounting Pronouncements

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Jul. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	3. DISCONTINUED OPERATIONS On May 3, 2019, the Company exchanged its inventory for forgiveness of accrued unpaid rent. Concurrent with the exchange management with the appropriate level of authority determined to discontinue the operations of the product segment. As of July 31, 2024 and 2023, accounts payable and accrued expenses related to these operations had a balance of $ 51,000

SHAREHOLDERS_ DEFICIT

SHAREHOLDERS’ DEFICIT	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
SHAREHOLDERS’ DEFICIT	4. SHAREHOLDERS’ DEFICIT The Company has one class of Preferred Stock. Holders of Series B Preferred Stock are entitled to vote with the holders of common stock as a single class on all matters. We are currently authorized to issue an aggregate of 401,000,000 400,000,000 1,000,000 Series B Preferred Stock is not redeemable by the Company and has a liquidation value of $ 100 10 No The Company did no

BASIC AND DILUTED LOSS PER SHAR

BASIC AND DILUTED LOSS PER SHARE	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
BASIC AND DILUTED LOSS PER SHARE	5. BASIC AND DILUTED LOSS PER SHARE Basic net loss per common share is computed by dividing net loss attributable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed giving effect to all dilutive potential common shares that were outstanding during the period. Diluted potential common shares consist of incremental shares issuable upon conversion of preferred stock. In computing diluted net loss per share for the years ended July 31, 2024 and 2023, no

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Jul. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	6. RELATED PARTY TRANSACTIONS Dr. Hsiao and directors Dr. Frost and Rao Uppaluri and former director Steve Rubin are each stockholders, current or former officers and/or directors or former directors of Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (“Asensus”), which was a publicly-traded medical device company until August 2024. Dr. Frost is a director and over 5 The Company signed a five year 10 1,250 0 no 0 The Company is under common control with multiple entities and the existence of that control could result in operating results or financial position of each individual entity significantly different from those that would have been obtained if the entities were autonomous. One of those related parties, OPKO Health, Inc. (“OPKO”) and the Company are under common control and OPKO has a one percent ownership interest in the Company that OPKO has accounted for as an equity method investment due to the ability to significantly influence the Company.

NOTES PAYABLE _ RELATED PARTY

NOTES PAYABLE – RELATED PARTY	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE – RELATED PARTY	7. NOTES PAYABLE – RELATED PARTY Notes payable- related party are summarized in the following table (in thousands): SCHEDULE OF NOTES PAYABLE- RELATED PARTY As of July 31, 2024 As of July 31, 2023 (a) Notes payable- Frost Gamma Investments Trust $ 350 $ 150 (b) Notes payable- Dr. Jane Hsiao 150 150 Total Notes payable - related party $ 500 $ 300 (a) As of July 31, 2023, the Company had outstanding notes payable Frost Gamma Investments Trust (“Frost Gamma”) in the aggregate principal amount of $ 150,000 75,000 75,000 11 July 31, 2025 On August 15, 2023, the Company entered into a new promissory note agreement with Frost Gamma in the principal amount of $ 200,000 11 July 31, 2025 no 350,000 (b) As of July 31, 2023, the Company had outstanding notes payable Jane Hsiao, Ph.D. (“Dr. Hsiao”) in the aggregate principal amount of $ 150,000 75,000 75,000 11 July 31, 2025 There were no 150,000

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	8. COMMITMENTS AND CONTINGENCIES Leases The Company was under an operating lease agreement for our corporate office space that expired in 2012. The lease currently continues on a month-to-month basis at no cost.

ACCOUNTS PAYABLE AND ACCRUED EX

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	12 Months Ended
	Jul. 31, 2024
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	9. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses from continuing operations are summarized in the following table (in thousands): SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES July 31, 2024 July 31, 2023 Accounts payable $ 80 $ 209 Accrued redemption 10 10 Accrued other 20 21 Total $ 110 $ 240 Accounts payable was reviewed for outdated vendor accounts during the period ending July 31, 2024. It was determined that an estimated $ 118,000

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES The Company accounts for income taxes using the asset and liability method. Pursuant to this method, deferred tax assets and liabilities are established for the differences between the financial reporting and the tax bases of the Company’s assets and liabilities and net operating loss carryforwards at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The accounting for uncertain tax positions guidance under ASC 740 requires that we recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent The Company files its tax returns in the U.S. federal jurisdiction and with U.S. states. The Company is subject to tax audits in all jurisdictions for which it files tax returns. Tax audits by their very nature are often complex and can require several years to complete. There are currently no tax audits that have commenced with respect to income tax or any other returns in any jurisdiction. Tax years ranging from 2020 to 2023 remain open to examination by various taxing jurisdictions as the statute of limitations has not expired. Because the Company is carrying forward income tax attributes, such as net operating losses and tax credits from earlier tax years, these attributes can still be audited when utilized on returns filed in the future. It is the Company’s policy to include income tax interest and penalties expense in its tax provision. The difference between income taxes at the statutory federal income tax rate of 21 SCHEDULE OF FEDERAL INCOME TAX RATE AND INCOME TAXES July 31, 2024 % July 31, 2023 % Income tax benefit at the federal statutory rate from continuing operations $ (49 ) 21.0 $ (42 ) 21.0 State income taxes, net of effect of federal taxes (10 ) 4.3 (9 ) 4.5 Expired net operating losses 0 - 364 (182.8 ) Change in valuation allowance 59 (25.3 ) (313 ) 157.3 Total $ - - $ - - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets consist of the following (in thousands): SCHEDULE OF DEFERRED TAX ASSETS July 31, 2024 July 31, 2023 Federal and State net operating loss $ 3,830 $ 3,768 Foreign net operating loss 18 18 Other - 3 Gross deferred tax assets 3,848 3,789 Less: Valuation allowance (3,848 ) (3,789 ) Net deferred tax asset $ - $ - At July 31, 2024, the Company had available Federal and State net operating loss carry forwards of approximately $ 14.8 0.1 2.1 net operating losses can only be used to reduce taxable income by 80 percent A valuation allowance is required to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a full $ 3.8 3.8 59,000 313,000 no

SUBSEQUENT EVENT

SUBSEQUENT EVENT	12 Months Ended
	Jul. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENT	11. SUBSEQUENT EVENT On September 25, 2024, the Company entered into a Promissory Note in the principal amount of $ 25,000.00 10 11

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Consolidation	Consolidation
Discontinued Operations	Discontinued Operations
Use of Estimates	Use of Estimates
Cash and Cash Equivalents	Cash and Cash Equivalents 25,000 7,000
Income Taxes	Income Taxes The Company files its tax returns as prescribed by the laws of the jurisdictions in which it operates. Tax years ranging from 2020 to 2023 remain open to examination by various taxing jurisdictions as the statute of limitations has not expired. The net operating losses are generally subject to examination up to three years after the utilization of such losses. It is the Company’s policy to include income tax interest and penalty expense in its tax provision.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
Loss Contingencies	Loss Contingencies
Related Parties	Related Parties
Recent Accounting Pronouncements	Recent Accounting Pronouncements

NOTES PAYABLE _ RELATED PARTY (

NOTES PAYABLE – RELATED PARTY (Tables)	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE- RELATED PARTY	Notes payable- related party are summarized in the following table (in thousands): SCHEDULE OF NOTES PAYABLE- RELATED PARTY As of July 31, 2024 As of July 31, 2023 (a) Notes payable- Frost Gamma Investments Trust $ 350 $ 150 (b) Notes payable- Dr. Jane Hsiao 150 150 Total Notes payable - related party $ 500 $ 300

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	12 Months Ended
	Jul. 31, 2024
Payables and Accruals [Abstract]
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES	Accounts payable and accrued expenses from continuing operations are summarized in the following table (in thousands): SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES July 31, 2024 July 31, 2023 Accounts payable $ 80 $ 209 Accrued redemption 10 10 Accrued other 20 21 Total $ 110 $ 240

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
SCHEDULE OF FEDERAL INCOME TAX RATE AND INCOME TAXES	SCHEDULE OF FEDERAL INCOME TAX RATE AND INCOME TAXES July 31, 2024 % July 31, 2023 % Income tax benefit at the federal statutory rate from continuing operations $ (49 ) 21.0 $ (42 ) 21.0 State income taxes, net of effect of federal taxes (10 ) 4.3 (9 ) 4.5 Expired net operating losses 0 - 364 (182.8 ) Change in valuation allowance 59 (25.3 ) (313 ) 157.3 Total $ - - $ - -
SCHEDULE OF DEFERRED TAX ASSETS	The tax effects of temporary differences that give rise to significant portions of the deferred tax assets consist of the following (in thousands): SCHEDULE OF DEFERRED TAX ASSETS July 31, 2024 July 31, 2023 Federal and State net operating loss $ 3,830 $ 3,768 Foreign net operating loss 18 18 Other - 3 Gross deferred tax assets 3,848 3,789 Less: Valuation allowance (3,848 ) (3,789 ) Net deferred tax asset $ - $ -

ORGANIZATION AND BUSINESS (Deta

ORGANIZATION AND BUSINESS (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net losses from continuing operations	$ 113,000	$ 199,000
Accumulated deficit	28,847,000	28,734,000
Cash	25,000	$ 7,000
Working capital	$ 127,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	Jul. 31, 2024	Jul. 31, 2023
Accounting Policies [Abstract]
Deposit in bank	$ 25,000	$ 7,000

DISCONTINUED OPERATIONS (Detail

DISCONTINUED OPERATIONS (Details Narrative) - USD ($)	Jul. 31, 2024	Jul. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Accounts payable and accrued expenses	$ 51,000	$ 51,000

SHAREHOLDERS_ DEFICIT (Details

SHAREHOLDERS’ DEFICIT (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Class of Stock [Line Items]
Capital stock, shares authorized	401,000,000
Common stock, shares authorized	400,000,000	400,000,000
Preferred stock, designated shares	1,000,000
Preferred stock, dividends declared	$ 0	$ 0
Common Stock [Member]
Class of Stock [Line Items]
Number of shares issued	0	0
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, designated shares	100	100
Preferred stock liquidation value, per share value	$ 100
Dividends payable amount per share	$ 10

BASIC AND DILUTED LOSS PER SH_2

BASIC AND DILUTED LOSS PER SHARE (Details Narrative) - shares	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Earnings Per Share [Abstract]
Weighted average outstanding common shares dilution adjustment	0	0

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Jan. 01, 2008	Feb. 29, 2016	Jul. 31, 2024	Jul. 31, 2023
Dr. Phillip Frost [Member]
Related Party Transaction [Line Items]
Lease term	5 years
Rental payments	$ 1,250	$ 0
Rent expense			$ 0	$ 0
Rent payable			$ 0	$ 0
Dr. Phillip Frost [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Beneficial ownership percentage	10%
Dr. Phillip Frost [Member] | Cocrystal Pharma, Inc [Member]
Related Party Transaction [Line Items]
Beneficial ownership percentage			5%

SCHEDULE OF NOTES PAYABLE- RELA

SCHEDULE OF NOTES PAYABLE- RELATED PARTY (Details) - USD ($)	Jul. 31, 2024	Jul. 31, 2023
Frost Gamma Investments Trust [Member]
Defined Benefit Plan Disclosure [Line Items]
Total Notes payable - related party	$ 350,000	$ 150,000
Dr. Jane Hsiao [Member]
Defined Benefit Plan Disclosure [Line Items]
Total Notes payable - related party	150,000	150,000
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total Notes payable - related party	$ 500,000	$ 300,000

NOTES PAYABLE _ RELATED PARTY_2

NOTES PAYABLE – RELATED PARTY (Details Narrative) - USD ($)		12 Months Ended
	Aug. 15, 2023	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2021
Frost Gamma Investments Trust [Member]
Short-Term Debt [Line Items]
Notes, description			the Company had outstanding notes payable Frost Gamma Investments Trust (“Frost Gamma”) in the aggregate principal amount of $150,000, which pertained to promissory notes issued in fiscal 2021 and 2022, in the principal amount of $75,000 and $75,000, respectively. The promissory notes accrue interest at a rate of 11% per annum, payable on the maturity date on July 31, 2025, as amended on August 15, 2023. The Frost Gamma promissory note may be prepaid in advance of the maturity date without penalty. Frost Gamma is a trust controlled by Dr. Phillip Frost, a current director of the Company, and who beneficially owns in excess of 10% of the Company’s common stock.
Notes payable		$ 350,000	$ 150,000
Frost Gamma Investments Trust [Member] | Promissory Note [Member]
Short-Term Debt [Line Items]
Notes, description	the Company entered into a new promissory note agreement with Frost Gamma in the principal amount of $200,000, which also accrues interest at a rate of 11% per annum, payable on the maturity date on July 31, 2025. This promissory note may also be prepaid in advance of the maturity date without penalty. There were no payments made on the promissory notes to Frost Gamma during the fiscal year ended July 31, 2024, and as such, total outstanding notes payable balance was $350,000 as of the fiscal year then ended.
Promissory notes, principal amount	$ 200,000			$ 75,000	$ 75,000
Accrued interest rate	11%		11%
Maturity date	Jul. 31, 2025		Jul. 31, 2025
Payments on promissory notes		0
Dr. Jane Hsiao [Member]
Short-Term Debt [Line Items]
Notes, description			the Company had outstanding notes payable Jane Hsiao, Ph.D. (“Dr. Hsiao”) in the aggregate principal amount of $150,000, which pertained to promissory notes issued in fiscal 2021 and 2022, in the principal amount of $75,000 and $75,000, respectively. The promissory notes accrue interest at a rate of 11% per annum, payable on the maturity date on July 31, 2025, as amended on August 15, 2023. The promissory notes to Dr. Hsiao may be prepaid in advance of the maturity date without penalty. Dr. Hsiao is the Company’s Chairman and Interim CEO, and who beneficially owns in excess of 10% of the Company’s common stock.
Notes payable		150,000	$ 150,000
Dr. Jane Hsiao [Member] | Promissory Note [Member]
Short-Term Debt [Line Items]
Promissory notes, principal amount				$ 75,000	$ 75,000
Accrued interest rate			11%
Maturity date			Jul. 31, 2025
Payments on promissory notes		$ 0

SCHEDULE OF ACCOUNTS PAYABLE AN

SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Payables and Accruals [Abstract]
Accounts payable	$ 80	$ 209
Accrued redemption	10	10
Accrued other	20	21
Total	$ 110	$ 240

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details Narrative)	12 Months Ended
	Jul. 31, 2024 USD ($)
Payables and Accruals [Abstract]
Accounts payable adjustment	$ 118,000

SCHEDULE OF FEDERAL INCOME TAX

SCHEDULE OF FEDERAL INCOME TAX RATE AND INCOME TAXES (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income tax benefit at the federal statutory rate from continuing operations	$ (49)	$ (42)
Income tax benefit at the federal statutory rate from continuing operations, percent	21%	21%
State income taxes, net of effect of federal taxes	$ (10)	$ (9)
State income taxes, net of effect of federal taxes, rate	4.30%	4.50%
Expired net operating losses	$ 0	$ 364
Expired net operating losses, rate		(182.80%)
Change in valuation allowance	$ 59	$ (313)
Change in valuation allowance, rate	(25.30%)	157.30%
Total
Total Percentage

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Federal and State net operating loss	$ 3,830	$ 3,768
Foreign net operating loss	18	18
Other		3
Gross deferred tax assets	3,848	3,789
Less: Valuation allowance	(3,848)	(3,789)
Net deferred tax asset

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Effective Income Tax Rate Reconciliation [Line Items]
Income tax likelihood percentage description	greater than 50 percent
Statutory federal income tax rate	21%	21%
Operating loss carryforwards not subject to expiration	$ 2,100,000
Reduce taxable income percentage description	net operating losses can only be used to reduce taxable income by 80 percent
Deferred tax assets, valuation allowance	$ 3,848,000	$ 3,789,000
Increase (decrease) in valuation allowance	59,000	(313,000)
Income taxes paid	0	$ 0
Federal and State Jurisdiction [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Operating loss carryforwards	14,800,000
Foreign Tax Jurisdiction [Member]
Effective Income Tax Rate Reconciliation [Line Items]
Operating loss carryforwards	$ 100,000

SUBSEQUENT EVENT (Details Narra

SUBSEQUENT EVENT (Details Narrative) - 2024 Frost Gamma Note [Member] - Subsequent Event [Member] - USD ($)	Oct. 23, 2024	Sep. 25, 2024
Subsequent Event [Line Items]
Promissory note principal amount	$ 30,000	$ 25,000
Interest rate percentage	11%	11%
Dr Philip Frost [Member]
Subsequent Event [Line Items]
Beneficially owned percentage	10%	10%